Skip to content

Thyroid and breast nodules ultrasound intelligent scan system

Thyroid and breast nodules ultrasound intelligent scan system

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500100527
Enrollment
Unknown
Registered
2025-04-10
Start date
2025-04-10
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Classification of thyroid and breast nodules and their ultrasound counterparts

Interventions

Gold Standard:The gold standard is the result of interpreting and labeling suspicious lesions by multiple senior sonographers.
Index test:Thyroid and breast nodules ultrasound intelligent scan system

Sponsors

Beijing Friendship Hospital ,Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Patients who come to our department for thyroid or breast ultrasound between January 2022 and November 2026 based on clinical needs;

Exclusion criteria

Exclusion criteria: 1. Thyroid or breast nodules have received minimally invasive, chemotherapy, radiotherapy and other treatments within 6 months before the examination; 2.(2) Poor image quality or incomplete data, does not meet the requirements of artificial intelligence learning.

Design outcomes

Primary

MeasureTime frame
Accuracy;Sensitivity;Specificity;

Countries

China

Contacts

Public ContactZhang Weicong

Beijing Friendship Hospital ,Capital Medical University

1689152107@qq.com+86 10 6192 1677

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026